Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Journal of the American Society of Nephrology : JASN|July 1, 1994
Experimental renal failure in the rat modulates cardiac Na,K-ATPase alpha 2 mRNA but not proteinJ C da Silva, X J Shi, C A Johns, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 4, 2018
Discussing Conservative Management With Older Patients With CKD: An Interview Study of NephrologistsKeren Ladin, Renuka Pandya, Allison Kannam, et al.
Kidney360|March 26, 2021
Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical TrialStephen L Seliger, Terry Watnick, Andrew D Althouse, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2021
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A <i>Post Hoc</i> Analysis of the TEMPO 3:4 TrialJudith E Heida, Ron T Gansevoort, Vicente E Torres, et al.
Kidney Medicine|May 1, 2024
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered RegistryElise Hoover, Vanessa Holliday, Nicole Merullo, et al.
The American Journal of Physiology|September 1, 1995
Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epitheliumR D Perrone, S A Grubman, L C Rogers, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 30, 2020
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney DiseaseVicente E Torres, Arlene B Chapman, Olivier Devuyst, et al.
Kidney International Reports|September 12, 2022
A Systematic Review of Reported Outcomes in ADPKD StudiesSara S Jdiaa, Nedaa M Husainat, Razan Mansour, et al.
Kidney Medicine|April 17, 2025
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control DataRonald D Perrone, Diana Garbinsky, Sasikiran Nunna, et al.
Scientific Reports|March 11, 2020
Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trialPeter Janssens, François Jouret, Bert Bammens, et al.
Pageof 16